We are live on ! Find out more
IG

Ithaka Group Portfolio holdings

AUM $482M
1-Year Est. Return 15.81%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+15.81%
3 Year Est. Return
+99.18%
5 Year Est. Return
+112.16%
10 Year Est. Return
+745.06%
AUM
$643M
AUM Growth
+$47.8M
Cap. Flow
-$13.1M
Cap. Flow %
-2.04%
Top 10 Hldgs %
55.4%
Holding
41
New
2
Increased
1
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$16.8M
2
BURL icon
Burlington
BURL
+$12M
3
ADSK icon
Autodesk
ADSK
+$18.8K

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$6.94M
2
META icon
Meta Platforms (Facebook)
META
+$5.81M
3
AMZN icon
Amazon
AMZN
+$2.61M
4
MA icon
Mastercard
MA
+$901K
5
CRM icon
Salesforce
CRM
+$744K

Sector Composition

Rank Sector Weight
1 Technology 31.67%
2 Financials 21.69%
3 Consumer Discretionary 21.08%
4 Healthcare 14.47%
5 Communication Services 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
26
Autodesk
ADSK
$44.3B
$11.3M 1.75%
85,860
+142
+0.2% +$18.8K
WDAY icon
27
Workday
WDAY
$33.4B
$11M 1.72%
91,059
-659
-0.7% -$84.4K
ALXN
28
DELISTED
Alexion Pharmaceuticals
ALXN
$9.74M 1.51%
78,422
-1,744
-2% -$204K
VRTX icon
29
Vertex Pharmaceuticals
VRTX
$121B
$9.19M 1.43%
54,080
-843
-2% -$131K
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$11.5B
$5.52M 0.86%
58,626
-1,015
-2% -$88.9K
JCI icon
31
Johnson Controls International
JCI
$87.5B
$3.78M 0.59%
112,997
ADNT icon
32
Adient
ADNT
$1.6B
$863K 0.13%
17,549
AAPL icon
33
Apple
AAPL
$4.89T
$648K 0.1%
14,000
AMT icon
34
American Tower
AMT
$77.7B
$461K 0.07%
3,200
SBUX icon
35
Starbucks
SBUX
$118B
$241K 0.04%
4,930
-200
-4% -$11.4K
PG icon
36
Procter & Gamble
PG
$343B
$234K 0.04%
3,000
EQIX icon
37
Equinix
EQIX
$107B
$215K 0.03%
500
PANW icon
38
Palo Alto Networks
PANW
$264B
$204K 0.03%
5,952
-672
-10% -$22.4K
GE icon
39
GE Aerospace
GE
$367B
$157K 0.02%
2,400
INCY icon
40
Incyte
INCY
$23.5B
-83,269
Closed -$6.94M

Similar funds

Ithaka Group's Q2 2018 Portfolio in Review

As of Q2 2018, Ithaka Group held 41 positions worth $643M, up 8% from $595M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Ithaka Group's Q2 2018 filing shows 2 new, 1 increased, 29 reduced and 2 closed positions. Its largest new stake was Edwards Lifesciences: 359,451 shares worth $17.4M. The largest sale was Incyte, an estimated $6.94M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ithaka Group's largest Q2 2018 buy was Edwards Lifesciences: 359,451 shares worth $17.4M.
  • Ithaka Group added most to Autodesk in Q2 2018, an estimated $18.8K increase.
  • Ithaka Group's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $5.81M.
  • Ithaka Group fully exited Incyte in Q2 2018, selling an estimated $6.94M.
  • Ithaka Group's ten largest holdings make up 55% of its $643M portfolio in Q2 2018.
  • Ithaka Group opened 2 new positions and closed 2 in Q2 2018.
  • Ithaka Group's portfolio value rose 8% quarter-over-quarter to $643M.

Based on Ithaka Group's 13F filing for Q2 2018, filed 13 Aug 2018.